Iovance Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 27.31 M | $256.48 M | 5.25% | 9.01% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 26.62 M | $249.94 M | 2.64% | 8.78% |
| MHR FUND MANAGEMENT LLC | 11/14/2024 | 24.00 M | $225.33 M | 0.00% | 7.91% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 21.48 M | $201.73 M | 100.00% | 7.08% |
| STATE STREET CORP | 11/14/2024 | 13.20 M | $123.97 M | 4.57% | 4.35% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 8.53 M | $80.08 M | 12.99% | 2.81% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 8.14 M | $76.48 M | 198.07% | 2.69% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 5.86 M | $55.04 M | 185.85% | 1.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 5.65 M | $53.05 M | -2.38% | 1.86% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 4.80 M | $45.11 M | -6.02% | 1.58% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 4.53 M | $42.56 M | 9.68% | 1.49% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 4.47 M | $42.00 M | -1.50% | 1.47% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 4.39 M | $41.22 M | 67.44% | 1.45% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 4.24 M | $39.81 M | -63.76% | 1.40% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 4.03 M | $37.87 M | 59.02% | 1.33% |
| MACQUARIE GROUP LTD | 11/14/2024 | 3.19 M | $29.95 M | 100.00% | 1.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.10 M | $29.14 M | -10.90% | 1.02% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 3.04 M | $28.56 M | 43.72% | 1.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.45 M | $23.01 M | 13.09% | 0.81% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.41 M | $22.60 M | 1.69% | 0.79% |
| MORGAN STANLEY | 11/14/2024 | 2.15 M | $20.18 M | -23.89% | 0.71% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.07 M | $19.44 M | -8.65% | 0.68% |
| JANE STREET GROUP, LLC | 11/15/2024 | 1.99 M | $18.68 M | 100.00% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.91 M | $17.96 M | -3.62% | 0.63% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.89 M | $17.77 M | -44.94% | 0.62% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 1.68 M | $15.77 M | 2.64% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.41 M | $13.28 M | 42.58% | 0.47% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.40 M | $13.15 M | -6.67% | 0.46% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 1.36 M | $14.36 M | -29.98% | 0.45% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.32 M | $12.41 M | -0.45% | 0.44% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 1.28 M | $12.05 M | 75.36% | 0.42% |
| C WORLDWIDE GROUP HOLDING A/S | 11/05/2024 | 1.26 M | $11.83 M | 0.00% | 0.42% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 1.22 M | $11.46 M | 0.94% | 0.40% |
| SIREN, L.L.C. | 11/13/2024 | 1.11 M | $10.39 B | 100.00% | 0.36% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 1.05 M | $9.88 M | 14.40% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.02 M | $9.61 M | 320.88% | 0.34% |
| ORION INVESTMENT CO | 11/13/2024 | 906,285 | $8.51 M | 14.04% | 0.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 902,268 | $8.66 M | -1.94% | 0.30% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 876,009 | $8.23 M | 100.00% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 841,969 | $7.91 M | -18.63% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 807,100 | $7.58 M | -18.41% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 794,500 | $7.46 M | 28.50% | 0.26% |
| BOXER CAPITAL, LLC | 11/14/2024 | 750,000 | $7.04 M | 0.00% | 0.25% |
| QVT FINANCIAL LP | 11/14/2024 | 678,564 | $6.37 M | 0.00% | 0.22% |
| APIS CAPITAL ADVISORS, LLC | 11/14/2024 | 675,000 | $6.34 M | 100.00% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 656,700 | $6.17 M | 54.96% | 0.22% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 652,966 | $6.13 M | -9.83% | 0.22% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 631,130 | $5.93 M | 91.23% | 0.21% |
| UBS GROUP AG | 11/14/2024 | 622,129 | $5.84 M | -21.76% | 0.21% |
| BARCLAYS PLC | 11/19/2024 | 604,584 | $5.68 M | 118.81% | 0.20% |
Iovance Biotherapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 366 institutional investors and hedge funds held shares of Iovance Biotherapeutics, Inc.. The most heavily invested institutionals were:
CVA Family Office, LLC: 0
VANGUARD GROUP INC: 27.31 M
PERCEPTIVE ADVISORS LLC: 26.62 M
MHR FUND MANAGEMENT LLC: 24 M
BlackRock Funding, Inc. /DE: 21.48 M
STATE STREET CORP: 13.2 M
77.31% of Iovance Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 261.39 M shares in the last 24 months. This purchase volume represents approximately $1.54 B in transactions.